Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Berlin plans six vast COVID-19 vaccination centres handling 4,000 people a day

Thu, 26th Nov 2020 15:32

By Caroline Copley

BERLIN, Nov 26 (Reuters) - Berlin is racing to open six mass
vaccination centres capable of handling up to 4,000 people per
day by mid-December, the project coordinator told Reuters on
Thursday, as the city waits for authorities to approve the first
vaccines.

An empty trade fair hall, two airport terminals, a concert
arena, a velodrome and an ice rink will be turned into six
vaccination centres where it plans to administer up to 900,000
shots against the coronavirus in the first three months.

Albrecht Broemme said plans envisage 3,000 to 4,000 people
per day being ferried through each centre in the same way as
shoppers are guided through IKEA stores in one direction.

"The biggest challenge will be succeeding in getting the
right people at the right time at the right vaccination centre,"
Broemme said on the sidelines of a fire drill at the city's
makeshift COVID-19 hospital in a trade fair hall.

Germany appears to be the furthest ahead of European nations
in its planning for the daunting logistical and administrative
challenge that could be just a few weeks away if the first
vaccines gain approval.

Europe's drug watchdog expects to receive the first
application for conditional marketing approval for a COVID-19
vaccine "in the coming days", it said on Thursday, the latest
step towards making a shot available outside the United States.

Broemme said Berlin is working on the assumption that around
80% of its doses in the first instance will come from Pfizer
/BioNTech with the remaining 20% of the doses
from AstraZeneca.

Health Minister Jens Spahn said Germany has secured around
300 million vaccine doses. Other German states have said
vaccination centres will be ready from mid-December and mobile
teams will inoculate the most vulnerable.

Elsewhere in Europe, preparations appear mixed.

In Spain, the government aims to vaccinate a substantial
part of its population in the first half of 2021 and has opted
to use trucks rather than centres to distribute the shots.

Italy expects to have vaccinated most Italians by next
September and is due to set out detailed plans on Dec. 2. France
has said it could start administering shots as soon as the end
of the year and will unveil its strategy next week.

Britain plans to roll out vaccines using a mixture of
centres and doctors' practices and is aiming to have enough
shots to have some sort of normality after Easter.

In contrast, Hungary and Bulgaria are not expecting to
receive their first shipments until Spring.

Berlin's vaccination centres will be open seven days a week
and on public holidays from 0900 to 1900, Broemme said, with the
aim of completing the first phase within three months. After
that people will get shots at doctors' practices and pharmacies.

Those aged over 75 and healthcare workers are expected to be
first-in-line, the city's health senator said last week.

One challenge will be finding enough staff to operate the
centres, which will need medical professionals, stewards and
security guards. EasyJet has offered some of its
first-aid trained staff, a spokesman said.

Broemme expects each person to spend around one hour in the
centre. People will be monitored for side effects for around 30
minutes after receiving a shot amid strict social-distancing and
hygiene standards.
(Reporting by Caroline Copley
Additional reporting by Alistair Smout and Sarah Young in
London, Emilio Paradi in Milan, Emma Pinedo Gonzalez in Madrid,
Matthias Blamont in Paris, Krisztina Than in Budapest, Tsvetelia
Tsolova in Sofia)

More News
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more
2 Jan 2024 12:01

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.